🇺🇸 FDA
Patent

US 9011874

Compositions, methods and uses for poxvirus elements in vaccine constructs

granted A61KA61K2039/5256A61K39/00

Quick answer

US patent 9011874 (Compositions, methods and uses for poxvirus elements in vaccine constructs) held by Takeda Vaccines, Inc. expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5256, A61K39/00, A61K39/12, A61K39/145